ChinaDaily Briefs

Daily Brief China: NetEase , Meituan, Guangzhou Automobile Group, HKBN Ltd, CK Hutchison Holdings, Shanghai Fosun Pharmaceutical (Group), China Merchants Port, PC Partner, DiDi Global, Jiangsu Zenergy Battery Technologies and more

In today’s briefing:

  • Hang Seng Indexes: FAF Methodology Change for Secondary Listings; Over US$1bn to Buy in NetEase
  • Meituan (3690 HK): 4Q24, High Growth and Higher Margin, 60% Upside
  • A/H Premium Tracker (To 21 Mar 2025):  AH Premia Still Falling; Expect Curve Torsion or AH Widening
  • Merger Arb Mondays (24 Mar) – HKBN, ESR, Canvest, Vesync, Seven & I, Proto, Makino, Spartan
  • Weekly Deals Digest (23 Mar) – CK Hutchison, Canvest, ENN Energy, HKBN, Fengxiang, Spartan, DN Sols
  • China Healthcare Weekly (Mar.23)-Fosun Pharma Sells United Family Healthcare, MNC’s Inflection Point
  • China Merchants Port (144 HK): Will It Have a Role in CKH’s Port Sale?
  • PC Partners (1263 HK): SGX Primary Listing Justified To Maintain NVIDIA Supply
  • Didi Global Q424 Results: Another Set of Solid Numbers from China’s Ride Hailing Giant
  • Jiangsu Zenergy Battery Technologies Pre- IPO – The Positives – Brisk Volume-Led Growth


Hang Seng Indexes: FAF Methodology Change for Secondary Listings; Over US$1bn to Buy in NetEase

By Brian Freitas


Meituan (3690 HK): 4Q24, High Growth and Higher Margin, 60% Upside

By Ming Lu

  • In 4Q24, Meituan’s revenue growth rate was 20% YoY with all businesses rising.
  • The operating margin improved to 8.8% in 4Q24 versus about zero in 4Q23.
  • We set an upside of 61% and a price target of HK$270. Buy.

A/H Premium Tracker (To 21 Mar 2025):  AH Premia Still Falling; Expect Curve Torsion or AH Widening

By Travis Lundy

  • AH Premia continue to fall. Spread curve torsion was a barbell this week. Narrow and wide spreads see Hs outperform. Middling spreads outperform less.
  • To me, warning signs are flashing on spreads. They are at their narrowest in 5yrs and they are volatile, though volatility is coming down.
  • Lots of spreads see the HA premium less than 15%. That is historically tight.


Weekly Deals Digest (23 Mar) – CK Hutchison, Canvest, ENN Energy, HKBN, Fengxiang, Spartan, DN Sols

By Arun George


China Healthcare Weekly (Mar.23)-Fosun Pharma Sells United Family Healthcare, MNC’s Inflection Point

By Xinyao (Criss) Wang

  • Given new policy recommendations, it is only a matter of time before HPV vaccination is included in the national immunization program, which is detrimental to HPV vaccine companies.
  • MNCs have seen a inflection point in performance growth in 2024 in China. Although VBP/NRDL negotiation are negative factors, is it also due to any consideration to withdraw from China?
  • Fosun Pharma has agreed to sell its entire stake in United Family Healthcare to Calcite Gem Investments Group for US$124.1 million. We shared our views about the deal.

China Merchants Port (144 HK): Will It Have a Role in CKH’s Port Sale?

By Osbert Tang, CFA

  • China Merchants Port (144 HK) may potentially play a role in CK Hutchison Holdings (1 HK)‘s port portfolio disposal should the mainland government want to step in. 
  • While CMPH’s size is small relative to the port portfolio, its parent China Merchants Group and sister China Merchants Bank H (3968 HK) can easily facilitate such a transaction.
  • Having the portfolio in the hands of mainland company is desirable to the Chinese government. Even if CMPH has no role, its 7.6x PER and 6% yield are attractive.

PC Partners (1263 HK): SGX Primary Listing Justified To Maintain NVIDIA Supply

By David Blennerhassett

  • On the 18th June 2024, PC Partner (1263 HK)‘s board said it was considering an SGX listing, by way of introduction, and applying for the withdrawal of the HKEx listing.
  • A 30th August 2024 announcement provided clarity on a step-by-step approach for the HKEx withdrawal. A secondary listing on the SGX was established on the 15th November.
  • The next step is to establish a dual-primary listing in Singapore. Then withdraw the HKEx listing. The key driver behind this exercise is ensure the uninterrupted supply of NVIDIAs GPUs.

Didi Global Q424 Results: Another Set of Solid Numbers from China’s Ride Hailing Giant

By Daniel Hellberg

  • Most key P&L items and revenue drivers improved Y/Y and sequentially vs Q324
  • Although GTV per transaction dipped slightly, estimated “take rate” improved in Q424
  • Strong OpCF obviates need for quick FY25 IPO — but it could still happen this year

Jiangsu Zenergy Battery Technologies Pre- IPO – The Positives – Brisk Volume-Led Growth

By Akshat Shah

  • Jiangsu Zenergy Battery Technologies (JSZENERGY CH) (Zenergy) is looking to raise up to US$300m in its upcoming HK IPO.
  • Zenergy is an EV and energy storage system battery manufacturer providing integrated battery solutions, encompassing battery cells, modules, packs and battery management systems dedicated to large-scale applications of electrochemical products.
  • In this note, we talk about the positive aspects of the deal.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars